Jade Biosciences, Inc. Common Stock JBIO Q1 2026 earnings
Reported May 7, 2026 · Before market open
EPS estimate-$0.52
Next report
Aug 12, 2026 (in 2 months)EPS estimate-$0.66
Financials
Q1 2026Valuation & ratios
Versus estimates
Diluted EPS
Ask the moment Jade Biosciences, Inc. Common Stock reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI

Claude
Questions, answered.
- When did Jade Biosciences, Inc. Common Stock report Q1 2026 earnings?
- Jade Biosciences, Inc. Common Stock (JBIO) reported Q1 2026 earnings on May 7, 2026 before market open.
- What were Jade Biosciences, Inc. Common Stock's Q1 2026 revenue and EPS?
- Jade Biosciences, Inc. Common Stock reported diluted EPS of $-0.57 for Q1 2026.
- Did Jade Biosciences, Inc. Common Stock beat estimates in Q1 2026?
- EPS missed the consensus estimate of $-0.52 by $0.05.
- How did Jade Biosciences, Inc. Common Stock's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, diluted EPS declined 533.3% from $-0.09.
- Where can I find Jade Biosciences, Inc. Common Stock's Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-211973) and the 10-Q periodic report (0001193125-26-212088) directly on SEC EDGAR. The filing index links above go to sec.gov.